High-Dose Adenosine for Treatment of Refractory Supraventricular Tachycardia in an Emergency Department of an Academic Medical Center: A Case Report and Literature Review
- PMID: 26818382
- DOI: 10.1016/j.jemermed.2015.11.012
High-Dose Adenosine for Treatment of Refractory Supraventricular Tachycardia in an Emergency Department of an Academic Medical Center: A Case Report and Literature Review
Abstract
Background: Symptomatic tachycardia is a common admission diagnosis in the emergency department (ED). This can be a life-threatening condition and requires immediate attention. Supraventricular tachycardia (SVT) is commonly treated with adenosine, and successful treatment is limited to atrioventricular (AV) node-dependent SVTs as adenosine causes a transient heart block. However, there are limited data available for instances when the recommended dosing regimen (6 mg, 12 mg, 12 mg) fails to terminate SVT.
Case report: A 33-year old man was evaluated in the ED with an electrocardiogram revealing a regular narrow complex tachycardia with a heart rate of 180 beats/min and a rhythm consistent with SVT. He reported experiencing 3 days of fatigue, myalgias, palpitations, and dyspnea on exertion, but was otherwise hemodynamically stable. Attempts at chemical cardioversion with standard doses of adenosine (6 mg, 12 mg, and 12 mg) were given without success. After consultation with the cardiology service, additional doses of 24 mg and then 36 mg of adenosine were administered. The last dose of 36 mg produced sustained conversion and return to a normal sinus rhythm. The patient later underwent radiofrequency ablation of a left-sided orthodromic reciprocating accessory pathway. After 3 months of medical management, the patient had an implantable cardiac defibrillator placed for prevention of sudden cardiac death. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Each case of SVT demands immediate attention from an emergency physician. It is imperative that providers be aware of the limitations of adenosine and when it may be appropriate to deviate from standard dosing recommendations. This is in addition to collaborating with an expert in cardiac electrophysiology when initial management tactics are not successful.
Keywords: adenosine; cardioversion; dysrhythmias; emergency department; supraventricular tachycardia.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Exploring Treatment Protocol Adherence and Variations in Paroxysmal Supraventricular Tachycardia in the Emergency Department: A Multi-Center Cohort Study.Med Sci (Basel). 2025 May 9;13(2):58. doi: 10.3390/medsci13020058. Med Sci (Basel). 2025. PMID: 40407553 Free PMC article.
-
High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review.Cardiol Young. 2017 Jul;27(5):981-984. doi: 10.1017/S1047951116002626. Epub 2016 Dec 19. Cardiol Young. 2017. PMID: 27989257 Review.
-
Comparison of initial adenosine dose conversion rate for supraventricular tachycardia in the emergency department.Am J Emerg Med. 2024 Nov;85:117-122. doi: 10.1016/j.ajem.2024.08.044. Epub 2024 Sep 3. Am J Emerg Med. 2024. PMID: 39255683
-
Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review.Ann Emerg Med. 1999 Feb;33(2):185-91. doi: 10.1016/s0196-0644(99)70392-6. Ann Emerg Med. 1999. PMID: 9922414
-
Emergency department management of the pediatric patient with supraventricular tachycardia.Pediatr Emerg Care. 2007 Mar;23(3):176-85; quiz 186-9. doi: 10.1097/PEC.0b013e318032904c. Pediatr Emerg Care. 2007. PMID: 17413437 Review.
Cited by
-
Comparing methods of adenosine administration in paroxysmal supraventricular tachycardia: a pilot randomized controlled trial.BMC Cardiovasc Disord. 2022 Jan 26;22(1):15. doi: 10.1186/s12872-022-02464-5. BMC Cardiovasc Disord. 2022. PMID: 35081915 Free PMC article. Clinical Trial.
-
Administration of Adenosine Triphosphate Provides Additional Value Over Programmed Electrophysiologic Study in Confirmation of Successful Ablation of Atrioventricular Accessory Pathways.Front Cardiovasc Med. 2021 Nov 16;8:716400. doi: 10.3389/fcvm.2021.716400. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34869625 Free PMC article.
-
Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges.Front Psychiatry. 2018 Mar 12;9:68. doi: 10.3389/fpsyt.2018.00068. eCollection 2018. Front Psychiatry. 2018. PMID: 29593579 Free PMC article. No abstract available.
-
Cardiorespiratory Effects of Three Infusion Doses of Adenosine in Conscious Goats: A Preliminary Study.Vet Sci. 2021 Aug 6;8(8):158. doi: 10.3390/vetsci8080158. Vet Sci. 2021. PMID: 34437480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials